常规机械通气下呼吸暂停试验用于脑死亡评估
该回顾性研究纳入2016至2022年连续接受脑死亡评估呼吸暂停试验的92例成人患者,其中58例(63%)采用机械通气技术,32例(35%)采用氧吹入技术,2例(2%)技术记录缺失。机械通气组低氧血症发生率为0/58,氧吹入组为4/32(12.5%)(p=0.01);低血压发生率机械通气组为3/58(5%),氧吹入组为4/32(12.5%)(p=0.24)。多因素分析显示氧吹入技术是呼吸暂停试验期间患者不稳定的独立预测因素(OR 37.74,95%CI 2.74-520.14)。作者结论认为常规机械通气下呼吸暂停试验可行,并具有若干潜在优势。
要点
- 机械通气组低氧血症(SpO2<90%)发生率为0/58,氧吹入组为4/32(12.5%),p=0.01。
- 氧吹入技术是呼吸暂停试验期间患者不稳定的独立预测因素(OR 37.74,95%CI 2.74-520.14)。
- 92例中3例(3%)呼吸暂停试验未能成功完成:氧吹入组2例(1例低氧血症、1例低血压),机械通气组1例(因血流动力学不稳定中止)。
- 低血压(平均动脉压<65 mm Hg despite 升压药滴定)发生率机械通气组3/58(5%)vs 氧吹入组4/32(12.5%),p=0.24。
- 作者结论认为常规机械通气下呼吸暂停试验可行,并具有若干潜在优势。
适用人群与场景
- 2016至2022年间在本机构接受脑死亡评估呼吸暂停试验的连续成人患者。
- 研究期间本机构批准政策变更,允许在常规机械通气下进行呼吸暂停试验。
- 呼吸暂停试验技术的选择由主治医师决定。
处置流程与药物剂量
- 本机构于2016年批准政策变更,允许在常规机械通气下进行呼吸暂停试验(原文未写明具体操作步骤)。
- 呼吸暂停试验技术(机械通气或氧吹入)由主治医师决定。
红旗征与不能漏的情况
- 呼吸暂停试验期间患者不稳定,包括SpO2<90%的低氧血症、平均动脉压<65 mm Hg despite 升压药滴定的低血压、心律失常、气胸和心脏骤停。
研究设计与关键结果
- 回顾性研究,纳入92例成人患者:58例(63%)采用机械通气技术,32例(35%)采用氧吹入技术,2例(2%)技术记录缺失。
- 呼吸暂停试验未能成功完成3/92(3%):氧吹入组2例(1例低氧血症、1例低血压),机械通气组1例(因血流动力学不稳定中止)。
- 低氧血症发生率:机械通气组0/58 vs 氧吹入组4/32(12.5%),p=0.01。
- 低血压发生率:机械通气组3/58(5%)vs 氧吹入组4/32(12.5%),p=0.24。
- 多因素分析:氧吹入技术是呼吸暂停试验期间患者不稳定的独立预测因素(OR 37.74,95%CI 2.74-520.14)。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为常规机械通气下呼吸暂停试验可行,并具有若干潜在优势。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The use of continuous positive airway pressure has been shown to improve the tolerance of the apnea test, a critical component of brain death evaluation. The ability to deactivate the apnea backup setting has made apnea testing possible using several conventional mechanical ventilators. Our goal was to evaluate the safety and efficacy of apnea testing performed on mechanical ventilation, compared with the oxygen insufflation technique, for the determination of brain death.
METHODS: This was a retrospective study. In 2016, our institution approved a change in policy to permit apnea testing on conventional mechanical ventilation. We examined the records of consecutive adults who underwent apnea testing as part of the brain death evaluation process between 2016 and 2022. Using an apnea test technique was decided at the discretion of the attending physician. Outcomes were successful apnea test and the occurrence of patient instability during the test. This included oxygen desaturation (SpO2) < 90%, hypotension (mean arterial pressure < 65 mm Hg despite titration of vasopressor), cardiac arrhythmia, pneumothorax, and cardiac arrest.
RESULTS: Ninety-two adult patients underwent apnea testing during the study period: 58 (63%) with mechanical ventilation, 32 (35%) with oxygen insufflation, and 2 (2%) lacked documentation of technique. Apnea tests could not be completed successfully in 3 of 92 (3%) patients-two patients undergoing the oxygen insufflation technique (one patient with hypoxemia and one patient with hypotension) and one patient on mechanical ventilation (aborted for hemodynamic instability). Hypoxemia occurred in 4 of 32 (12.5%) patients with oxygen insufflation and in zero patients on mechanical ventilation (p = 0.01). Hypotension occurred during 3 of 58 (5%) tests with mechanical ventilation and 4 of 32 (12.5%) tests with oxygen insufflation (p = 0.24). In multivariate analysis, the use of oxygen insufflation was an independent predictor of patient instability during the apnea test (odds ratio 37.74, 95% confidence interval 2.74-520.14).
CONCLUSIONS: Apnea testing on conventional mechanical ventilation is feasible and offers several potential advantages over other techniques.
参考来源
- Merchant RA, Ahmad SN, Haddix B, et al. Apnea Testing on Conventional Mechanical Ventilation During Brain Death Evaluation. Neurocrit Care. 2024. PMID: 38664328. doi:10.1007/s12028-024-01990-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。